Currently out of the existing stock ratings of Lawrence Biegelsen, 117 are a BUY (55.19%), 81 are a HOLD (38.21%), 14 are a SELL (6.6%).

Lawrence Biegelsen

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Biegelsen, currently employed at WELLS FARGO, carries an average stock price target met ratio of 68.7% that have a potential upside of 13.74% achieved within 161 days.

Lawrence Biegelsen’s has documented 789 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DXCM, DexCom at 17-Feb-2026.

Wall Street Analyst Lawrence Biegelsen

Analyst best performing recommendations are on NARI (INARI MEDICAL ).
The best stock recommendation documented was for NARI (INARI MEDICAL ) at 3/10/2021. The price target of $125 was fulfilled within 1 day with a profit of $6.73 (5.69%) receiving and performance score of 56.9.

Average potential price target upside

of $96.4 (26.29%) on EAR (EARGO ).
of $59.24 (26.43%) on PODD (INSULET).
of $46.26 (11.25%) on COO (THE COOPER COMPANIES COMMON STOCK).

ALC Alcon AG BDX Becton Dickinson and Company BSX Boston Scientific Corp DXCM DexCom EAR Eargo GKOS Glaukos Corp GMED Globus Medical ISRG Intuitive Surgical LUNG Pulmonx Corp MMSI Merit Medical Systems NPCE Neuropace NVRO Nevro Corp SWAV Shockwave Medical TFX Teleflex TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings NUVA NuVasive PODD Insulet EW Edwards Lifesciences Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Thomas Stephan (STIFEL)